The article discusses recent analyst ratings for TransMedics Gr, showing a mix of bullish and bearish perspectives. The average price target has declined by 5.1%, indicating a potential negative sentiment. However, the company's strong financial performance, including high revenue growth and profitability, may offset the negative impact of the lowered price targets. This results in a neutral short-term impact on the stock price.